[Changing prevalence of overweight and obesity among Chinese children aged 6-15 from 2009-2019]

J N Yuan1, B H Jin1, S T Si2

  • 1Department of Endocrinology , the Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310052, China.

Insights

Overweight and obesity rates in Chinese children aged 6-15 increased from 2009-2019, particularly in boys. While obesity growth slowed, overweight prevalence rose, highlighting regional and gender disparities in childhood weight issues.

Area of Science:

  • Pediatrics
  • Public Health
  • Epidemiology

Background:

  • Childhood overweight and obesity are significant global health concerns.
  • Understanding trends in prevalence is crucial for developing effective public health strategies.

Purpose of the Study:

  • To analyze the 10-year trends (2009-2019) in overweight and obesity prevalence among Chinese children aged 6-15.
  • To identify regional, age-specific, and gender-specific patterns in these trends.

Main Methods:

  • Utilized national multi-center epidemiological survey data from 2009-2010 and 2017-2019.
  • Included 14,597 children aged 6-15 from four diverse regions (Beijing, Tianjin, Zhejiang, Guangxi).
  • Employed t-tests and chi-square tests to assess changes in Body Mass Index (BMI) standard deviation scores (SDS) and prevalence rates.

Main Results:

  • Overall overweight rates increased from 17.1% to 19.1% (annual growth 0.20%), while obesity rates showed no significant change (11.8% to 12.5%).
  • Significant increases in overweight and obesity were observed in the Eastern region, and overweight increased in the Northern region.
  • The Southern region showed a decrease in obesity rates, while boys, particularly those aged 8-11, exhibited a prominent rise in overweight and obesity combined.

Conclusions:

  • The growth rate of childhood obesity in China has slowed, but overweight prevalence continues to rise, expanding the overall affected population.
  • Significant regional, age, and gender disparities exist in childhood weight status.
  • Personalized prevention and control strategies are necessary to address the varied characteristics of the obesity epidemic in Chinese children.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
716
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
16
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
19
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
733
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
949
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
21